Clinical Trial Update: Fecal Microbiota and Monocyte Trained Immunity in CHD Patients With Different hsCRP

View source ↗

Summary

Clinical trial update on fecal microbiota and monocyte trained immunity in coronary heart disease and unstable angina; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Unstable Angina

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Coronary Heart Disease, Unstable Angina | Status: COMPLETED